 GAITHERSBURG, Md., Nov. 22, 2021 GLOBE NEWSWIRE -- Altimmune, Inc. Nasdaq: ALT, a clinical-stage biopharmaceutical company, today announced that members of the Companys management team will be presenting virtually at the following conferences: 